Dr Reddy's Laboratories
Dr Reddy's Laboratories Ltd is an India-based multinational pharmaceutical company engaged in providing affordable and innovative medicines. The company operates through three main business segments: Global Generics, Pharmaceutical Services and Active Ingredients, and Proprietary Products. Core revenue drivers are the manufacture and sale of generic prescription formulations, active pharmaceutical ingredients, over-the-counter medicines, and biosimilars. Its principal end markets include retail pharmacies, hospital networks, and healthcare providers in the United States, India, Russia, and European markets. Dr Reddy's holds a leading market position as one of the major generic pharmaceutical companies originating from India. Dr Reddy's Laboratories Ltd is headquartered in Hyderabad, India, and its shares are traded on the National Stock Exchange of India, the BSE, and the New York Stock Exchange.
24 of the funds FundTelligence covers report a position in Dr Reddy's Laboratories.
- Legal name
- Dr Reddy's Laboratories Ltd
- Sector
- Health Care
- Country
- India
- Funds holding it
- 24
Funds holding Dr Reddy's Laboratories
- JPM India Fund — JPM · 3.55 % (full portfolio disclosed, June 2026)
- JPM Emerging Markets Sustainable Equity Fund — JPM · 0.9 % (full portfolio disclosed, June 2026)
- Templeton Emerging Markets Fund — Franklin Templeton · 0.59 % (full portfolio disclosed, September 2026)
- Templeton BIC Fund — Franklin Templeton · 0.57 % (full portfolio disclosed, September 2026)
- Indecap Guide Tillväxtmarknadsfond — Indecap · 0.55 % (full portfolio disclosed, June 2026)
- Handelsbanken Vekstmarked Tema — Handelsbanken · 0.41 % (full portfolio disclosed, September 2026)
- KLP AksjeFremvoksende Markeder Mer Samfunnsansvar — KLP · 0.37 % (full portfolio disclosed, June 2026)
- Storebrand Emerging Markets Plus — Storebrand · 0.36 % (full portfolio disclosed, October 2026)
Showing the 8 largest of 24 funds holding it.